TipRanks
Go Ultimate55% OFF

Lyell Immunopharma (LYEL) Balance Sheet

Lyell Immunopharma Balance Sheet

Lyell Immunopharma's total assets for Q2 2026 were $311.15M, a decrease of 11.26% from the previous quarter. LYEL total liabilities were $77.34M for the fiscal quarter, a 0.49% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 340.05M$ 490.86M$ 750.03M$ 937.56M$ 1.13B
$ 91.85M$ 108.03M$ 95.08M$ 104.31M$ 197.62M
$ 248.20M$ 382.82M$ 654.95M$ 833.25M$ 929.79M

Currency in USD

Lyell Immunopharma Debt to Assets

0400M800M1.2B8 %16 %24 %32 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets